Carmaxipine tablet orange peel book information (same as freehand medicine intelligent Edition)

This orange peel book database is jointly produced by yaozhi.com and tonghuayi.com Drug name: carbamazepine tablet specification: 0.1g/0.2g the active ingredient of carbamazepine (English) carbamazepine the active ingredient of Novartis It is a kind of benzodiazepine anticonvulsant and antiepileptic drug It is clinically used for anticonvulsant and antiepileptic, anti neuropathic pain, anti manic depression, improving the symptoms of some mental diseases, and anti central diabetes insipidus The more common adverse reactions are the reactions of central nervous system, such as blurred vision, diplopia and nystagmus The original manufacturer of carbamazepine tablets was Novartis Pharma K.K (Tegretol, 200mg) In July 1992, the product with specification of 100mg was listed in Japan with the trade name of "Tegretol" At the same time, carbamazepine tablets were listed in the United States by Novartis on March 11, 1968, with the trade name of Tegretol and the specification of 200mg In addition, camasippies are listed in the UK, Sweden, the Netherlands and other European countries Carbamazepine tablets were first approved in China in 1983 At present, there are 137 production approvals with specifications of 0.1g and 0.2g, all of which have been included in the 2012 edition of the national catalogue of essential drugs According to the selection principle of national reference preparation, the product of Novartis Pharma K.K company in Japan is recommended as the reference preparation for consistency evaluation, with the trademark name of Tegretol and specifications of 100mg and 200mg BCS classification (U.S.) drug name BCS classification trademark file carbamazepine 2 trademark and the BCS classification summarized by the U.S Food and Drug Administration (2011) PDF BCS classification (who) drug name BCS classification specification file carbamazepine 200mg BCS classification published by the World Health Organization (2005) PDF recommended reference drug name trademark For details of reference holding companies and listed countries, please refer to carbamazepine tablets (100mg / 200mg) Tegretol (12486g / 200mg) Novartis Pharma K.K Japan for domestic approval (see more) (137) drug name approval document No specification manufacturer approval time: carbamazepine tablets Guoyao Zhuzi h35020778 0.1g Guoyao holding star shark Pharmaceutical (Xiamen) Co., Ltd July 31, 2015 Guoyao Zhuzi h35020779 0.2g Guoyao holding Xingsha Pharmaceutical (Xiamen) Co., Ltd July 31, 2015 Guoyao Zhuzi h35020060 0.1g Fujian Sanming Tiantai Pharmaceutical Co., Ltd June 9, 2015 Guoyao Zhuzi h35020059 0.2g Fujian Sanming Tiantai Pharmaceutical Co., Ltd June 9, 2015 Guoyao Zhuzi h35020876 0.1g Fujian Fukang Pharmaceutical Co., Ltd September 24, 2015 KMZ h34023324 0.1g Shanghai Huayuan Changfu Pharmaceutical Group Jingde Pharmaceutical Co., Ltd May 7, 2015 KMZ h34021575 0.2g Anhui Renhe Pharmaceutical Co., Ltd June 16, 2015 KMZ h34020551 0.1g Anhui Renhe Pharmaceutical Co., Ltd June 16, 2015 Gjzz h34021534 0.1g Anhui Guosen Pharmaceutical Co., Ltd July 16, 2015 gjzz h62020277 0.1g Gansu Chengji biopharmaceutical Co., Ltd August 5, 2015 gjzz h62020510 0.1g Gansu Lanyao Pharmaceutical Co., Ltd August 18, 2015 gjzz h44020492 0.1g Guangzhou Huacheng pharmaceutical factory July 1, 2015 link address: http://db.yaozh.com/orangebook/aJ0=.html